Literature DB >> 24783030

An unusual presenting symptom of graves' disease: myalgia.

N Papanikolaou1, P Perros1.   

Abstract

A 50-year-old female patient presented with severe myalgia involving her proximal muscles for 3-4 weeks. She also reported mild thyrotoxic symptoms over the same time period. Examination revealed mild thyrotoxicosis, a moderate diffuse goiter and no eye signs. The clinical picture was dominated by muscle pain and tenderness involving mainly her proximal arms and legs, her calves and her fingers, requiring opiate analgesia. Muscle power and tendon reflexes were normal. Laboratory evaluation revealed undetectable serum thyroid stimulating hormone (TSH) with raised FT4, FT3 and positive TSH receptor antibodies. Treatment with carbimazole was started. Additional laboratory investigations were negative (inflammatory markers, creatine kinase and antibodies to antinuclear antibodies, gastric parietal cell, smooth muscle, mitochondrial, dsDNA, centromere, extractable nuclear antigen (ENA) ribonucleoprotein, ENA Sm, ENA Ro, ENA Anti-La, ENA Scl70, ENA Jo-1, anti-CCP and rheumatoid factor). Further assessment in the rheumatology clinic confirmed there was no small joint tenderness or loss of range of movement of her limbs, but widespread and profound muscle tenderness of the common extensors of the forearms, biceps, trapezius, calves and thighs. She was treated symptomatically with analgesic medication and continued on carbimazole. A month later she was euthyroid and her myalgia had resolved. Hyperthyroidism has a profound effect on skeletal muscle and often leads to myopathy. Severe myalgia in association with Graves' disease is rare and resolves with the restoration of euthyroidism.

Entities:  

Keywords:  Graves’ disease; Myalgia; Thyrotoxicosis

Year:  2012        PMID: 24783030      PMCID: PMC3821484          DOI: 10.1159/000343826

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  17 in total

1.  Thyrotoxicosis presenting as acute bulbar palsy.

Authors:  Betsy Mathew; Anup J Devasia; Vaggesh Ayyar; Vijayasree Thyagaraj; Geetha Ann Francis
Journal:  J Assoc Physicians India       Date:  2011-06

2.  Autoimmune thyroid disease with myasthenia gravis in a 28-year-old male: a case report.

Authors:  Imran Masood; Mir Yasir; Aiffa Aiman; R P Kudyar
Journal:  Cases J       Date:  2009-09-14

3.  Electromyography in thyrotoxicosis.

Authors:  I D Ramsay
Journal:  Q J Med       Date:  1965-07

Review 4.  Thyrotoxicosis.

Authors:  Jayne A Franklyn; Kristien Boelaert
Journal:  Lancet       Date:  2012-03-05       Impact factor: 79.321

5.  Hyperthyroid myopathy and the response to treatment.

Authors:  B R Olson; I Klein; R Benner; R Burdett; P Trzepacz; G S Levey
Journal:  Thyroid       Date:  1991       Impact factor: 6.568

6.  A case of Graves' disease associated with polymyositis.

Authors:  S Sakata; Y Fuwa; E Goshima; S Nakamura; N Yamakita; M Maeda; K Miura
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

Review 7.  Clinical review: Thyrotoxic periodic paralysis: a diagnostic challenge.

Authors:  Annie W C Kung
Journal:  J Clin Endocrinol Metab       Date:  2006-04-11       Impact factor: 5.958

Review 8.  Dysphagia as a manifestation of thyrotoxicosis: report of three cases and literature review.

Authors:  Wei-Yih Chiu; Chih-Chao Yang; I-Chueh Huang; Tien-Shang Huang
Journal:  Dysphagia       Date:  2004       Impact factor: 3.438

9.  Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain.

Authors:  Gregory A Plotnikoff; Joanna M Quigley
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

10.  Thyrotoxic myopathy: a clinical and quantitative analytic electromyographic study.

Authors:  K Puvanendran; J S Cheah; N Naganathan; P K Wong
Journal:  J Neurol Sci       Date:  1979-08       Impact factor: 3.181

View more
  1 in total

1.  Cross-sectional investigation of serum creatine kinase concentration in Graves disease patients treated with oral antithyroid drugs.

Authors:  Ying Cheng; Zhiyong Sun; Dapeng Zhong; Li Ren; Hang Yang
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.